Axsome Therapeutics Inc (AXSM)
90.02
-0.68
(-0.76%)
USD |
NASDAQ |
Nov 08, 16:00
90.02
0.00 (0.00%)
After-Hours: 20:00
Axsome Therapeutics Revenue (TTM): 291.49M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 291.49M |
March 31, 2024 | 251.02M |
December 31, 2023 | 270.60M |
Date | Value |
---|---|
September 30, 2023 | 223.44M |
June 30, 2023 | 182.49M |
March 31, 2023 | 144.61M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
144.61M
Minimum
Mar 2023
291.49M
Maximum
Jun 2024
227.28M
Average
237.23M
Median
Revenue (TTM) Benchmarks
Krystal Biotech Inc | 241.52M |
Pfizer Inc | 59.37B |
Sarepta Therapeutics Inc | 1.640B |
Moderna Inc | 4.988B |
NovaBay Pharmaceuticals Inc | 12.02M |